Similar Articles

Alternative electric tumor treatment areas in glioblastoma multiforme treatment: Rationale, preclinical and clinical studies

Ayşe Uyanık, Yusuf Bahap, Alpcan Ateş, Elif Özge Doğan, Oytun Erbaş

DOI: 10.5606/fng.btd.2017.027

Issue: 2017, Volume 3 - Issue 4
0 4383

Current trends in Glioblastoma

Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş

DOI: 10.5606/fng.btd.2021.25074

Issue: 2021, Volume 7 - Issue 3
9180 2205

Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations

Fatime Akgeyik, Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.144

Issue: 2024, Volume 10 - Issue 1
7394 2414

Genetically engineered mice models and generating glioblastoma multiforme in the brain

Yasin Polat, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.147

Issue: 2024, Volume 10 - Issue 1
4101 2644

Balancing Act: NRF2's contradictory roles in cancer progression and therapy

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.160

Issue: 2024, Volume 10 - Issue 3
9195 1787

In silico molecular docking analysis of chlorotoxin-derived peptide interaction with MMP-2

Alper Demirezen

DOI: 10.5606/fng.btd.2026.215

Issue: 2026, Volume 12 - Issue 1
20 102